Pharmaceutical giant Johnson & Johnson on Friday agreed to a $26 billion settlement to thousands of claims by local and state governments of the alleged role that it and several others played in the U.S. opioid crisis.
It makes sense, Brand says, that some people have doubts about allowing corporations with a history of prioritizing profits over people to be in charge of solving the pandemic.
